Brief: Independent Data Review Commences For Phase 2 Trial Of Psilocybin-Assisted Psychotherapy For Anxiety
18/01/2023 13:07
Jan 18 (Reuters) - Incannex Healthcare Ltd IHL.AX :
* INDEPENDENT DATA REVIEW COMMENCES FOR PHASE 2 TRIAL OF
PSILOCYBIN-ASSISTED PSYCHOTHERAPY FOR ANXIETY
Source text for Eikon: ID:nGNXbKYMdF
Further company coverage: IHL.AX
Recent news on Incannex Healthcare
See all newsBrief: Incannex Healthcare Says Computershare To Be Appointed As US Transfer Agent
Brief: Incannex Healthcare Says Federal Court Of Australia Approved Proposed Schemes Of Arrangement Between Incannex And Its Shareholders
Australia's Incannex up as shareholders in favour of US redomicile
Brief: Incannex Healthcare Will Prepare FDA Ind Application PSI-Gad
Brief: Review Of Ind Application For Ihl-42X By Us FDA Has Been Completed Clinical Trial For Patients With Obstructive Sleep Apnoea May Proceed